97. Ulcerative colitis
2,269 clinical trials,   1,331 drugs   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02825914
(ClinicalTrials.gov)
September 1, 201630/6/2016CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)Colitis, Ulcerative;Inflammatory Bowel DiseasesDietary Supplement: Casein glycomacropeptide (CGMP);Dietary Supplement: PlaceboUniversity of AarhusNULLCompleted18 YearsN/AAll80N/ADenmark
2NCT01534312
(ClinicalTrials.gov)
January 201213/2/2012Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)Colitis, Ulcerative;Inflammatory Bowel DiseasesDrug: CGMP protein;Drug: Maximal oral 5ASAUniversity of AarhusArla FoodsCompleted18 YearsN/ABoth24N/ADenmark